Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Prospective randomized single-blinded controlled clinical trial of percutaneous neuromodulation pain therapy device versus sham for the osteoarthritic knee: a pilot study
Kang RW, Lewis PB, Kramer A, Hayden JK, Cole BJ
Orthopedics 2007 Jun;30(6):439-445
clinical trial
4/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: No; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

This pilot study presents the initial results for a percutaneous neuromodulation pain therapy device (Neurowave) that is associated with no morbidity, good pain relief, and increased function in patients with knee osteoarthritis.
Reprinted with permission from SLACK Incorporated.

Full text (sometimes free) may be available at these link(s):      help